Central Florida Cancer Institute Foundation Inc is categorized under Hematologists in Davenport, FL and active since 2000.
Central Florida Cancer Institute Foundation Inc was established in 2000, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Randy Haysek at the company’s headquarters by writing to 40107 Highway 27, Davenport, Florida FL 33837 or by phoning (863) 419-0692. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Florida Cancer Institute Foundation Inc |
| Contact Person: | Randy Haysek |
| Address: | 40107 Highway 27, Davenport, Florida 33837 |
| Phone Number: | (863) 419-0692 |
| Website Address: | cfcancerinst.com |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2000 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hematologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Central Florida Cancer Institute Foundation Inc was started in 2000 to provide professional Hematologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Randy Haysek for inquiries that concern Central Florida Cancer Institute Foundation Inc by calling the company number (863) 419-0692, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Central Florida Cancer Institute Foundation Inc can be found at the coordinates 28.189834,-81.639584 as well as the street address 40107 Highway 27 in Davenport, Florida 33837.
For its online presence, you may visit Central Florida Cancer Institute Foundation Inc’s website at cfcancerinst.com and engage with its social media outlets through on Twitter and on Facebook.